Brian Rosenberger, VP, Commercial & Business Development at Zynerba Pharmaceuticals, Inc. (ZYNE), sold 4,289 shares at $1.10 ($5K) on 2022-07-19, disclosed to the SEC on 2022-07-20.
Open-market sale of $5k ZYNE by VP, Commercial & Business Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |